Vaporized Cannabis for Acute Migraine Yields Rapid, Sustained Relief

Source: Medscape

Apr 30, 2024 | Research

Vaporized cannabis containing THC and CBD may provide rapid and sustained relief of acute migraine pain with no serious side effects, new research suggests. In a single center randomized controlled trial across 247 treated migraine attacks, 4 puffs of vaporized THC-CBD mix were superior to placebo at achieving pain relief, pain freedom, and freedom from most bothersome symptoms at 2 hours. The THC-CBD mix was also superior to placebo for sustained pain freedom at 24 hours and sustained MBS freedom at 24 and 48 hours. The study was conducted by researchers at University of California San Diego Center for Pain Medicine; study results (Abstract S22.010) were presented on April 16 at the American Academy of Neurology (AAN) 2024 annual meeting.  Read the article here.


Click here to learn how STEM selects new articles.